367
Participants
Start Date
October 29, 2024
Primary Completion Date
May 27, 2025
Study Completion Date
May 27, 2025
VX-993
Tablets for oral administration.
HB/APAP
Capsules for oral administration.
Placebo (matched to VX-993)
Placebo matched to VX-993 for oral administration.
Placebo (matched to HB/APAP)
Placebo matched to HB/APAP for oral administration.
Atlanta Center for Medical Research, Atlanta
Clinical Pharmacology of Miami, Miami
ForCare Clinical Research, Tampa
Shoals Medical Trials Inc., Sheffield
Woodland International Research Group, Little Rock
Memorial Hermann Village, Houston
Endeavor Clinical Trials, San Antonio
BioBehavioral Research of Austin, Austin
JBR Clinical Research, Salt Lake City
Arizona Research Center, Phoenix
Trovare Clinical Research, Bakersfield
"New Hope Research Development , Tarzana, CA"
"HD Research LLC , First Surgical Hospital"
"HD Research LLC , Legent Orthopedic Hospital"
Vertex Pharmaceuticals Incorporated
INDUSTRY